Radius Health Business Update
22 avr. 2021 08h15 HE
|
Radius Health Inc.
Growth of 14% for new U.S. TYMLOS® patients in Q1, 2021 vs. Q4, 2020Q1, 2021 TYMLOS net revenue impacted by seasonality and distribution channel destockingApril, 2021 month-to-date new patient adds...
Radius Health to Announce First Quarter 2021 Financial Results, Host Conference Call and Live Webcast on Friday, May 7, 2021
20 avr. 2021 16h30 HE
|
Radius Health Inc.
BOSTON, April 20, 2021 (GLOBE NEWSWIRE) -- Radius Health (Nasdaq: RDUS) announced today that it will release its first quarter financial results on Friday, May 7, 2021. The Company will host a...
Radius Health Provides Update on Abaloparatide
24 mars 2021 08h00 HE
|
Radius Health Inc.
Regulatory success achieved in Japan by partner Teijin Pharma LimitedOstabaro® approved for treatment of male & female OP patients at high risk of fractureJapan is currently the largest anabolic...
Radius Health, Inc. Announces $175 Million Financing Transaction
03 mars 2021 16h15 HE
|
Radius Health Inc.
Repurchases $112.2 million of principal amount of the 3.00% convertible notes due September 1, 2024 (“2024 Notes”), representing approximately 37% of the outstanding 2024 NotesEstimated excess cash...
Radius Health, Inc.: Fourth Quarter and Full Year Results
25 févr. 2021 07h00 HE
|
Radius Health Inc.
Full year 2020 TYMLOS® U.S. net sales of $208 million was year-over-year growth of 20%Q4 2020 TYMLOS U.S. net sales: $60 million was 8% growth vs. Q4 2019 and 19% growth vs. Q3 2020New patient starts:...
Radius Health to Present at 10th Annual SVB Leerink Global Healthcare Conference
17 févr. 2021 08h30 HE
|
Radius Health Inc.
BOSTON, Feb. 17, 2021 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq: RDUS), today announced that it will provide a corporate update at the 10th Annual SVB Leerink Global Healthcare Conference at...
Radius Health to Announce Fourth Quarter 2020 Financial Results, Host Conference Call and Live Webcast on Thursday, February 25, 2021
16 févr. 2021 08h30 HE
|
Radius Health Inc.
BOSTON, Feb. 16, 2021 (GLOBE NEWSWIRE) -- Radius Health (Nasdaq: RDUS) announced today that it will release its fourth quarter financial results on Thursday, February 25, 2021. The Company will host...
Radius Health, Inc. Provides Abaloparatide Business Update
12 févr. 2021 12h33 HE
|
Radius Health Inc.
17% growth in January 2021 for new TYMLOS® patients vs. previous 4 month trailing averageHistomorphometry study published: Journal of Bone & Mineral Research in January 2021Cardiovascular safety...
Radius Health to Present at the 39th Annual J.P. Morgan Healthcare Conference
06 janv. 2021 12h00 HE
|
Radius Health Inc.
BOSTON, Jan. 06, 2021 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq: RDUS), today announced that Kelly Martin, President and CEO will present a virtual corporate update at the 39th Annual J.P....
Radius Health, Inc. Announces Acquisition of Orphan Disease Program
06 janv. 2021 06h00 HE
|
Radius Health Inc.
RAD011 is a pivotal-trial ready synthetic cannabidiol oral solution with potential utilization in multiple endocrine and metabolic orphan diseasesPrader-Willi syndrome (“PWS”) will be the initial...